A common theme emerging from recent antibody research is the development and validation of advanced diagnostic tools based on antibody detection. Multiple studies highlight the creation of novel biosensors and assays designed to enhance the sensitivity, specificity, and efficiency of detecting antibodies across various diseases.
Antibody research depends on sensitivity. Biointron explores how antigen quality and experimental conditions affect results and guide better antibody development.
Master affinity maturation from in vivo somatic hypermutation to in vitro selection. Biointron’s FCMES-AM™ platform accelerates optimization for higher binding and specificity.
You can also contact us on the Scientist and Science Exchange marketplaces.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
